Medicines Australia CEO Liz de Somer said, "The Productivity Commission research recognises that advances in cancer treatments have been one of the major drivers of productivity growth, and this is consistent with productivity studies from overseas."
-
Latest News
Let's make decisions based on credible information and not guesswork
The claims surrounding health system carbon emissions are being used to push significant changes in funding decisions and care delivery but rely on unpublished data, woolly assumptions and implausible assertions.
-
Latest News Productivity Commission research backs the benefit of faster access to medicines April 26, 2024
-
Latest News New research shows adult vaccination programs deliver major return on investment April 26, 2024Medicines Australia says a new report has revealed the significant benefits of investing in adult vaccination programs.
-
Latest News 'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved' April 24, 2024AstraZeneca has released a new episode of its recently launched TrailblAZers video podcast featuring New Zealand MP Todd Stephenson.
-
Latest News AusBiotech appoints experienced Sanofi leader as its new chief executive April 23, 2024The association's newly-appointed leader said, “I’m honoured to join AusBiotech as its incoming CEO, and to help the team build on the outstanding work delivered for members every day.”
-
Latest News Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate April 24, 2024Noxopharm CEO Dr Gisela Mautner said, “We are very grateful to the Tour de Cure team for funding this promising research. With this grant, our preclinical drug candidate is recognised as having potential that warrants further investigation and development."
-
Latest News Novartis nominates ex-BMS chief executive as its new chair April 24, 2024Novartis has announced that it will propose former CEO of Bristol Myers Squibb, Dr Giovanni Caforio, as the new chair of its board of directors.
-
Latest News Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all? April 23, 2024An NDIS participant with a chronic condition can enjoy a taxpayer-supported cruise with their support team. Does it make sense that, at the same time, they could be denied funded access to medicine or other health technology that could significantly improve their health and quality of life? Where is the equity and opportunity cost in that?
-
Podcast The Week in Review Podcast - 19 April April 19, 2024The 2024-25 Budget is fast approaching. We discuss what to look for, where to exercise caution, and what to ignore. More examples of where informing is confused with consulting leading to the problematic implementation of reform.
-
Latest News Rare Cancers Australia welcomes new appointments to its board of directors April 23, 2024RCA CEO Christine Cockburn said the appointments have been made at a good time as the organisation implements its new three-year strategic plan, which is focused on strengthening advocacy and outcomes for the rare cancer community.
-
Latest News NZ patients campaigning against Pharmac's decision to force a switch on insulin pumps April 23, 2024Diabetes patients in New Zealand are rebelling against the plan to forcibly switch their use of insulin pumps following a Pharmac tender.
-
Latest News BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics April 23, 2024Bristol Myers Squibb has joined Brandon Capital, a leading Australian life sciences private equity firm, in supporting Pathios Therapeutics' Series B financing.
-
Latest News Don't be alarmed by a flat or declining forecast, because it will rise over time April 22, 2024Do not be alarmed if the 2024-25 Budget reveals a flat or forecast decline in pharmaceutical spending over the four-year forward estimates - it will steadily rise as new medicines are added to the PBS.
-
Latest News Pharmacy groups welcome expanded flu vaccine program April 22, 2024Pharmacy groups have welcomed the Albanese Government's decision to fund pharmacists to provide National Immunisation Program influenza vaccines to aged care and disability homes.
-
Latest News Community organisations receive grants via Gilead's global ALL4LIVER program April 22, 2024"This is one of our largest community organisation focused grants for viral hepatitis in Australia and will help empower communities to tackle some of the fundamental obstacles to elimination by increasing awareness, testing and linkage to care across Australia,” said Gilead Australia and New Zealand general manager Jaime McCoy.
-
Latest News New Novartis-backed report identifies nuclear medicine opportunity but calls for change April 19, 2024"Nuclear medicines, like radioligand therapy, could be transformative for cancer care in Australia. Establishing clear pathways for market access and a thriving nuclear medicine industry will be key to enabling Australian patients to access these new treatment options," said Novartis country president Matt Zeller.
-
Latest News The HTA review reference committee members should ask themselves one question April 18, 2024Mark Butler's words should reverberate with the HTA review's reference committee as they prepare the final report. How will their recommendations address his public criticism of the 'clunky' and death-causing system?
-
Latest News Scope of practice review recommends formation of new committee April 19, 2024The second issues paper released by the Albanese Government's scope of practice review has proposed the creation of another advisory committee.
-
Latest News 'Under Karen’s leadership our local business has thrived both commercially and culturally' April 18, 2024“The decision to step down from my role at Sanofi is not one I came to lightly. Over 28 years this organisation and the teams I have had the privilege to lead have become an enormous part of my life,” said Karen Hood.
Australian Biotech
-
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
April 24, 2024 -
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
April 22, 2024 -
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
April 15, 2024 -
Monash Partners Comprehensive Cancer Consortium awards precision medicine grants
April 10, 2024 -
Chimeric secures US patent for its CHM 0201 cell therapy platform technology
April 8, 2024
Other Health
-
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024 -
Medibank offering members $50 to put towards dental out-of-pocket costs
February 7, 2024 -
US FDA approves Edwards' Evoque system for major heart valve disease
February 7, 2024 -
Private health insurers say price gouging doctors should be named and shamed
February 7, 2024 -
Medibank releases its top private health insurance claims for 2023
December 13, 2023
Latest Video
New Stories
-
New research shows adult vaccination programs deliver major return on investment
April 26, 2024 - - Latest News -
Productivity Commission research backs the benefit of faster access to medicines
April 26, 2024 - - Latest News -
Let's make decisions based on credible information and not guesswork
April 24, 2024 - - Latest News -
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
April 24, 2024 - - Latest News -
Novartis nominates ex-BMS chief executive as its new chair
April 24, 2024 - - Latest News -
'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved'
April 24, 2024 - - Latest News -
AusBiotech appoints experienced Sanofi leader as its new chief executive
April 23, 2024 - - Latest News